5.86
Electrocore Inc stock is traded at $5.86, with a volume of 58,692.
It is down -2.66% in the last 24 hours and down -22.69% over the past month.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
See More
Previous Close:
$6.02
Open:
$6.03
24h Volume:
58,692
Relative Volume:
0.88
Market Cap:
$47.37M
Revenue:
$32.03M
Net Income/Loss:
$-13.97M
P/E Ratio:
-3.4697
EPS:
-1.6889
Net Cash Flow:
$-8.25M
1W Performance:
-6.24%
1M Performance:
-22.69%
6M Performance:
+18.86%
1Y Performance:
-13.95%
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ECOR
Electrocore Inc
|
5.86 | 47.37M | 32.03M | -13.97M | -8.25M | -1.6889 |
|
ABT
Abbott Laboratories
|
103.99 | 180.70B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
327.44 | 125.40B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.17 | 102.80B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
79.34 | 45.74B | 6.07B | 1.06B | 1.34B | 1.8063 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
Published on: 2026-03-28 12:14:09 - baoquankhu1.vn
Growth Value: Whats the analyst consensus on electroCore IncEntry Point & Precise Entry and Exit Recommendations - baoquankhu1.vn
Retail Surge: Is electroCore Inc being accumulated by smart money2026 Chart Watch & AI Optimized Trade Strategies - baoquankhu1.vn
Earnings Beat: Is electroCore Inc stock overvalued or fairly priced2026 Short Interest & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Aug Update: Is electroCore Inc stock a value trap2026 WrapUp & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Aug Retail: Is electroCore Inc stock a value trap2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Market Review: Will electroCore Inc benefit from rate cuts2026 Trends & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
ElectroCore outlines 30% revenue growth potential for 2026 as leadership transition advances - MSN
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
Why Is electroCore, Inc. (ECOR) Stock Down Today? - Meyka
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - GuruFocus
Hedge Fund Moves: Does electroCore Inc meet Warren Buffetts criteria2026 Catalysts & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Offer Predictions for electroCore FY2030 Earnings - MarketBeat
CEO Moves: Should value investors consider electroCore IncMarket Risk Analysis & Reliable Entry Point Alerts - baoquankhu1.vn
Electrocore’s gammaCore Pipeline Faces Material Trial Disruption Risks From Regulatory, Enrollment and Operational Challenges - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Electrocore (ECOR) and Regeneron (REGN) - The Globe and Mail
ElectroCore FY earnings preview - MSN
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX) and Electrocore (ECOR) - The Globe and Mail
Major Insider Move at ElectroCore Signals Growing Confidence From the Top - TipRanks
ElectroCore Earnings Call: Growth Surges, Losses Deepen - TipRanks
ECOR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ElectroCore, Inc. (NASDAQ:ECOR) Q4 2025 earnings call transcript - MSN
ElectroCore, Inc. (ECOR) reports Q4 loss, lags revenue estimates - MSN
electroCore stock maintained at Buy by H.C. Wainwright, $18 target - Investing.com India
electroCore, Inc. (NASDAQ:ECOR) Q4 2025 Earnings Call Transcript - Insider Monkey
electroCore (ECOR) director Errico exercises warrants to acquire 42,055 shares - stocktitan.net
electroCore reports 27% revenue growth, CEO to retire By Investing.com - Investing.com India
electroCore Q4 2025 Earnings Call Transcript - MarketBeat
electroCore, Inc. 2025 Annual Report: Marketed Products, Business Strategy, Risks, and Regulatory Overview - Minichart
electroCore, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
electroCore (NASDAQ:ECOR) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
electroCore (ECOR) Q4 2025 Earnings Transcript - AOL.com
electroCore, Inc. (ECOR) Posts Fourth Quarter Loss, Misses Revenue Expectations - Bitget
Electrocore’s 2025 Earnings Call: Quell Sales Channels, VA Contract Status, and Fibromyalgia Launch Timelines Clash - Bitget
ECOR: Record revenue growth and leadership transition set the stage for 30% growth in 2026 - TradingView
electroCore Q4 Earnings Call Highlights - MarketBeat
ElectroCore says Dan Goldberger to retire as CEO effective April 1, 2026 - marketscreener.com
ECOR: Record revenue growth in 2025, leadership transition, and 30% growth targeted for 2026 - TradingView
electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
electroCore, Inc. reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Electrocore Q4 2025 reports strong revenue growth By Investing.com - Investing.com Canada
electroCore 10-K: $32.0M Revenue, $(13.97)M Net Loss - TradingView
ElectroCore announces full year 2025 financial results and organizational changes - marketscreener.com
Government-heavy revenue and risk profile at electroCore (NASDAQ: ECOR) - Stock Titan
electroCore (NASDAQ: ECOR) grows 2025 sales 27% but widens GAAP net loss - Stock Titan
ElectroCore Announces Full Year 2025 Financial Results and Organizational Changes - marketscreener.com
ElectroCore, Inc. Announces the Retirement of Dan Goldberger as Chief Executive Officer, Effective April 1, 2026 - marketscreener.com
electroCore, Inc. expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Aug Reactions: Will electroCore Inc outperform during market rallies2026 Decliners & AI Forecast for Swing Trade Picks - baoquankhu1.vn
ElectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 - 富途牛牛
electroCore to Participate at the 38th Annual Roth Conference - Bluefield Daily Telegraph
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):